Breast Cancer,HER2- Safety Analysis of Palbociclib with Fulvestrant/Letrozole in HR+/HER2- ABC: PARSIFAL Trial Mar 14, 2023
Lung Cancer A Phase 3 Study Investigated Cemiplimab-Induced PROs in aNSCLC Across Regions Mar 14, 2023
Lung Cancer Phase 3 Study: TMB Correlation with Pembrolizumab-Based Chemotherapy Outcomes in NSCLC Mar 14, 2023
Lung Cancer A Phase 3 Trial Comparing Lurbinectedin and Doxorubicin Combination Chemotherapy Mar 14, 2023
Skin Cancer Neoadjuvant Cemiplimab for Advanced Squamous-Cell Carcinoma: Promising Approach Mar 14, 2023
Gastrointestinal Cancer EMT-Related Genes Not Prognostic in Metastatic Colorectal Cancer: FIRE-3 Trial Mar 14, 2023
